INTRAVENOUS VERSUS SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) IN PREDIALYSIS CHILDREN

被引:0
|
作者
NAVARRO, M [1 ]
ALONSO, A [1 ]
MUNOZ, I [1 ]
GONZALEZ, M [1 ]
MESEGUER, CG [1 ]
机构
[1] CHILDRENS HOSP LA PAZ,RENAL UNIT,MADRID,SPAIN
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1402 / 1403
页数:2
相关论文
共 50 条
  • [1] RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) TREATMENT IN PREDIALYSIS PATIENTS
    AYAZ, M
    ATAMAN, R
    DALMAK, S
    SERDENGECTI, K
    ULKU, U
    EREK, E
    ONEN, K
    KIDNEY INTERNATIONAL, 1992, 41 (05) : 1466 - 1466
  • [2] SUBCUTANEOUS VERSUS INTRAVENOUS RECOMBINANT-HUMAN-ERYTHROPOIETIN ADMINISTRATION IN HEMODIALYSIS-PATIENTS
    BORAN, M
    DALVA, I
    YAZICIOGLU, A
    CETIN, S
    NEPHRON, 1993, 63 (01) : 113 - 114
  • [3] INTRAVENOUS VERSUS SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN PATIENTS ON HEMODIALYSIS AND CAPD
    EIDEMAK, I
    FRIEDBERG, MO
    LADEFOGED, SD
    LOKKEGAARD, H
    PEDERSEN, E
    SKIELBOE, M
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1992, 7 (06) : 526 - 529
  • [4] ONCE WEEKLY SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) IN HEMODIALYSIS-PATIENTS
    LAGO, M
    PEREZGARCIA, R
    DEVINUESA, MSG
    VILLAVERDE, M
    ANAYA, F
    VALDERRABANO, F
    KIDNEY INTERNATIONAL, 1994, 46 (02) : 579 - 579
  • [6] Subcutaneous (SC) versus intravenous (IV) administration of recombinant human erythropoietin (rHuEPO) in hemodialysis (HD) patients (pts).
    Kaufman, J
    Reda, D
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0910 - A0910
  • [7] EXPERIENCE WITH LOW-DOSE INTRAVENOUS AND SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN
    MCMAHON, LP
    DAWBORN, JK
    AMERICAN JOURNAL OF NEPHROLOGY, 1990, 10 (05) : 404 - 408
  • [8] THE USE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) IN HUMANS
    ADAMSON, JW
    ESCHBACH, JW
    CANCER SURVEYS, 1990, 9 (01) : 157 - 167
  • [9] EFFICACY OF ONCE WEEKLY SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) VS 3 TIMES A WEEK ADMINISTRATION IN HEMODIALYSIS
    LAGO, M
    PEREZGARCIA, R
    DEVINUESA, MSG
    ANAYA, F
    GOICOECHEA, M
    VILLAVERDE, M
    VALDERRABANO, F
    KIDNEY INTERNATIONAL, 1995, 48 (01) : 290 - 290
  • [10] RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) IN TREATING ANEMIA IN PREDIALYSIS CHRONIC-RENAL-FAILURE (CRF)
    WANG, QW
    LI, LS
    KIDNEY INTERNATIONAL, 1992, 42 (02) : 498 - 498